Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

High blood pressure? Consider hyperaldosteronism

Dreamstime.comIt is estimated that primary hyperaldosteronism is the cause of hypertension in as much as 5 per cent of patients. This article focuses of the two most common forms of this condition.


Early detection and treatment of primary hyperaldosteronism will improve morbidity and mortality, particularly because it means that stubborn hypertension can be managed in the optimal way. This article discusses signs and symptoms to look out for, diagnosis and management, which includes surgery. It focuses on drug treatment with spironolactone or eplerenone. 

CPD logo

To read the full article download the PDF above

Nadhia Bashir ClinDip, MRPharmS, specialist clinical pharmacist, Scott Akker MRCP, PhD, consultant endocrinologist, and Hasanin Khachi iPresc, MRPharmS, highly specialist pharmacist — specialist medicine, are all at Barts Health NHS Trust.




Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2013.11121258

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary information

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.